本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.7845
-0.0285-3.51%
盤後0.79570.0112+1.43%19:53 EDT
成交量:1.28萬
成交額:1.04萬
市值:399.49萬
市盈率:-0.13
高:0.8544
開:0.8365
低:0.7835
收:0.8130
52周最高:3.31
52周最低:0.7101
股本:509.23萬
流通股本:332.99萬
量比:0.52
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-6.0249
每股收益(LYR):-6.7096
淨資產收益率:-1708.61%
總資產收益率:-25.32%
市淨率:-0.91
市盈率(LYR):-0.12

資料載入中...

2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

SEC問詢函

[Cover]Correspondence
2019/07/24

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/15

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]